Reply to Authors

Affiliations

¹ Oncology, Ospedale Cannizzaro, Catania, Italy.
² Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland.
³ Department of Oncology, University Hospital of Geneva, Geneva, Switzerland.
⁴ Department of Oncology, University Hospital of Geneva, Geneva, Switzerland. Electronic address: alfredo.addeo@hcuge.ch.

Comment

Giuseppe Banna et al. ESMO Open. 2020 May.

. 2020 May;4(Suppl 2):e000809.

doi: 10.1136/esmoopen-2020-000809.

¹ Oncology, Ospedale Cannizzaro, Catania, Italy.
² Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland.
³ Department of Oncology, University Hospital of Geneva, Geneva, Switzerland.
⁴ Department of Oncology, University Hospital of Geneva, Geneva, Switzerland. Electronic address: alfredo.addeo@hcuge.ch.

No abstract available

Keywords: correspondence.

Comment on

How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere.
Banna G, Curioni-Fontecedro A, Friedlaender A, Addeo A. Banna G, et al. ESMO Open. 2020 Apr;5(2):e000765. doi: 10.1136/esmoopen-2020-000765. ESMO Open. 2020. PMID: 32245904 Free PMC article. Review.
How we treat patients with lung cancer during the SARS-CoV-2 pandemic.
Provencio M, Ruano-Raviña A. Provencio M, et al. ESMO Open. 2020 May;4(Suppl 2):e000785. doi: 10.1136/esmoopen-2020-000785. ESMO Open. 2020. PMID: 32409297 Free PMC article. No abstract available.